Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes, of course. I almost always feel it validating when a successful investor like Pizer buys in...even tho I have been diluted in effect. It gets the company closer to the goal line. I am a long term angel investor in startups, so I'm accustomed to it by now.
What is your background?
It seems Terren Peizer saw the great potential of BIVI and this patent challenge that led him to come aboard.
On July 3, 2018, BioVie, Inc., the Company, entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Acuitas Group Holdings, LLC (“Acuitas”) and certain other purchasers identified in the Purchase Agreement (together with Acuitas, the “Purchasers”)
Pursuant to the Purchase Agreement, Terren Peizer, the Chairman of Acuitas, was appointed as a member of the Company’s Board of Directors (the “Board”) and as the Chief Executive Officer of the Company, effective July 3, 2018. https://www.sec.gov/Archives/edgar/data/1580149/000152013819000027/bivi-20181231_10q.htm
Acuitas Group Holdings is >>>HUGE!!!
Terren Peizer
International financier
Terren Scott Peizer, dubbed the "Zelig of Wall Street", is an International Financier and Chairman of Los Angeles-based investment company, Acuitas Group Holdings. Peizer is Founder and Chairman of the three Acuitas companies, and is CEO of Catasys, Inc. and Crede Capital Group.
Born: 1959 (age 60 years), Beachwood, OH
Education: Wharton School of the University of Pennsylvania
Organizations founded: Hythiam, Inc., Clearant
https://en.wikipedia.org/wiki/Terren_Peizer
Terren S. Peizer
Founder, Chairman & CEO,Catasys, Inc. (Nasdaq:CATS)
Mr. Terren S. Peizer has been Chairman of BioVie Inc and also serves as its Chief Executive Officer and Director since July 3, 2018. He is Founder of Neurmedix, Inc. and serves as its Chairman and Chief Executive Officer. Mr. Peizer serves as Chairman and Managing Director at Crede CG II, Ltd. Mr. Peizer founded Catasys, Inc. (also known as Hythiam Inc.) in February 2003 and has been its Chairman and Chief Executive Officer since February 2003. He is Founder of Crede .
Board Members Memberships*
>>> Chairman and Managing Director
Crede CG II, Ltd.
>>> Founder, Chairman & CEO
Crede Capital Group LLC
>>> Founder, Chairman & CEO
Neurmedix, Inc.
>>> 2003-Present
Founder, Chairman & CEO
Catasys, Inc.
>>> 2018-Present
Chairman & CEO
BioVie Inc.
https://www.bloomberg.com/research/stocks/people/person.asp?personId=7337242&privcapId=7290234
Did you know, BIVI now under new Chairman and CEO Mr Terren Piezer who through his personal Acuitas Group Holdings acquired majority stake in the company?
He did to me as well. Nice guy.
OK, thanks.
I participated in their first equity offering - done privately - and persuaded some of my friends to take a stake as well. Needless to say, those shares and warrants are under water. Other earlier NNAB shares and more recent shares are not.
I agree with that statement...he reached out to me direct via email this morning about the 14-C filing.
No problem, and yes this is very under the radar.
FYI Tailwinds Research Group has equity holdings on BIVI. You can email Daniel Carlson : daniel@tailwindsresearch.com He's really accommodating to answer your questions.
BioVie Prepping For Nasdaq?
This morning BioVie (BIVI) filed a Pre14-C with the SEC. What this basically implies is an intent to list shares of BIVI on a major exchange; most likely the Nasdaq Capital Market.
In order to qualify for Nasdaq, the Company must meet a set of criteria laid out by the exchange. For the Nasdaq Capital Market (the easiest for which to qualify), the requirements are as follows:...
With this filing, BioVie is tipping their hand to the market. The Company fully intends to uplist onto a national exchange. In order to do so, they need to raise some money, so we can expect this. However, at Tailwinds, we are not worried about dilution. Instead, we think the Company is extremely undervalued and any possible transaction will just position them for an eventual takeout. We remain long BIVI and more excited than ever about the potential here.
https://tailwindsresearch.com/2019/04/biovie-prepping-for-nasdaq/
Thank you for posting this as well, but...please always pay attention to disclaimers, such as they have on the last line:
ejob, thanks for posting that link. It is annoying how beneath the radar BIVI is.
ejob, I had reviewed the filed form 4's and form 3's some months ago and they did not match what were the stated share holdings. I then suggested to the COO that they might want to catch up, which they have been doing. The disparity between transaction and filing dates was simply an oversight.
Perhaps it is a minor point and as a long since the days of the predecessor company NNAB I hope so, but "only one" is definitely not the same as "at least one."
That said, I expect BIVI will prevail on the majority of claims.
Terren did a reverse split with CATS a couple of years ago and it worked out...although it took some time to fully play out since their evaluation got cut in half. While rev splits suck...they can work out.
The bid hasn't retreated pre-market so that's good news so far...
Haven’t experienced a RS yet that hasn’t come out for the worse at the other end....sometimes a spike, and an opportunity to get out, immediately after split though
Uplisting news! I hate reverse splits but with Terren on board, I feel fine with this company action.
https://www.otcmarkets.com/filing/html?id=13382454&guid=J0e3UWxnK75MNth
I agree! I ain't chartist but sounds good. :0
VNDM is finally showing its actual share count on the ASK instead of the typical 5k/10k sizes - may be out of shares to short very soon. Also, the chart is about to shift up with the current RSI, Accum and MACD curling up. Won't be long as anticipation of good Phase 2A results may come on May 2nd!
Indeed! CATS is soaring to new highs! Will BIVI follow? Oh wait! Terren's in both houses'...
SLEEPING GIANT HERE.
BANK ON NEW MANAGEMENT PAST SUCCESS imo.
$BIVI
Institutional Ownership...while small, its worth keeping an eye on after the conference commences.
https://fintel.io/so/us/bivi
Right on! Take that VNDM(shortie). tic toc ...
I would hate to be "short" on this low floater and have them come out with successful clinical trials; and a possible buyout potential. May 2nd!!!
Very nice!
Also listed (About BioVie), "As of April 2019, all six of the planned patients had been treated with BIV201 therapy and the results are being analyzed for presentation to the Food & Drug Administration (“FDA”) in the first half of 2019."
Open question - if the results (at this point) were not forward looking, why seek capital from investors and spend the time making an official announcement for it? This tells me they are ramping up from a successful Phase 2a completion and thinking ahead to possible Phase 3 FDA trials which will require lots of capital/funding.
NEWS! BioVie to Present at ThinkEquity Conference in NYC on May 2nd
LOS ANGELES, April 24, 2019 (GLOBE NEWSWIRE) -- BioVie Inc. (OTCQB: BIVI) (“BioVie” or “Company”), a clinical-stage company developing innovative drug therapies for liver disease, announced that Mr. Terren Peizer, the Company’s Chairman and CEO, is scheduled to participate in the ThinkEquity Conference on May 2, 2019 in New York City. This event is dedicated to connecting small and micro-cap companies with high-level institutional and retail investors. Management will hold one-on-one meetings with investors during the conference.
Event details: BioVie will present a company overview and clinical trial update on Thursday, May 2, 2019 at the Mandarin Oriental Hotel in New York City at 2:00 pm Eastern Time. Following the event, a copy of the presentation will be available in the Investors section of the Company's website at:
www.biovieinc.com/investors.
https://irdirect.net/prviewer/release/id/3759533
It's about time!!!...TERREN's in the house!... Go BIVI !...
NEW SEC FILLING = GOOD MOVE! = GOOD SIGN!
Post-effective Amendment to Registration Statement (pos Am)
EXPLANATORY NOTE
DEREGISTRATION OF SECURITIES
This Post-Effective Amendment No. 1 is an amendment to the Registration Statement on Form S-1 (Reg. No. 333-215619) (the “Registration Statement”) of BioVie Inc. (the “Company”). On April 4, 2019, the Company notified Aspire Capital Fund, LLC pursuant to the terms of the common stock purchase agreement referred to in the Registration Statement that it was electing to terminate such agreement effective April 5, 2019 (the “Termination Date”). In accordance with the undertakings made by the Company to remove from registration, by means of a post-effective amendment, any of the securities registered under the Registration Statement which remain unsold at the termination of the offerings, the Company hereby removes from registration all securities registered under the Registration Statement which remained unsold as of the Termination Date.
https://ih.advfn.com/stock-market/USOTC/biovie-inc-BIVI/stock-news/79731614/post-effective-amendment-to-registration-statement
Clearly, funding is NO longer an issue as evidence by this SEC filing and of course with our Chairman & CEO, Mr. Terren Peizer running the company, IMO. Positive vibes going forward....Go BIVI !!!
Just MMs playing around. Big mistake for anyone who's shorting. Never mess with Terren! With the right news, this will skyrocket. IMO
All of the .08s are getting bid whacked today...a little yesterday too.
Thank you! Now we know who's accumulating big in the past 2 weeks?
BIVI Long&Strong!
Great summary of BIVI (BioVie) posted...account is free for newsletters.
https://tailwindsresearch.com/2019/04/biovie-an-undiscovered-gem/?unapproved=4739&moderation-hash=ecf30038383a1a3f6b8605d8f3d20fdf#comment-4739
Ascending wedge is forming off of .085c; last one was in the .04c range. My take is NITE was soaking up shares at .10c last Friday with CFGN selling into it to transfer shares...another run up is going to happen here soon if the flag formation holds.
Interesting! Looking forward to their DD coverage on BIVI. Good find and thanks!
Tailwinds Research Group just initiated coverage of BIVI (BioVie). No due diligence literature as of yet on the website, but curious to see his future thoughts once posted. Look under the Coverage tab at the top; CATS is also on there.
https://tailwindsresearch.com/
Nope. Seems NITE wants more! lol
This action today is very intriguing, it makes you wonder what's on the table next week. NITE just kept absorbing all the bidwhacked since the market start at 10 cents.
Have a good weekend!
Gut feeling they'll run up hard today. Fingers' crossed!!!
Oh My! Now CDEL joins NITE bidding @5000?
Holy Molly! Watching level 2? Bidwhacker is getting aggressive..But NITE is still showing only 5,000 shares ever since the market start. Could it be 500,000? 5,000,000?
Shhhhhhh.....it's a secret. NITE is busy absorbing every shares being bidwhacked.
Agree! It happened a small amount yesterday. CFGN is the likely culprit throwing into the bid.
Bid whacking going on. Somebody trying to put pressure to lower the price. Unfortunately for him/her, NITE is just absorbing everything not to mention only showing 5,000 shares. Seems NITE has a large block bid order but not totally revealing it. Bidwhacker/Short is in trouble!
Just buy and load up for the run.
Last year .30 run was just a TEASED.
This time around?
THE REAL RUN BEGINS $BIVI imo.
Glta.
I keep saying it...and I'll say it again. It won't be long here!!!
Once more traffic sees the potential here..we go up! The chart is consolidating for the next move up...just hoping it doesn't go up too fast and goes up in mitigated segments.
Shorts will be trapped for major squeeze! Don't mess with Terren.
Can't wait when that happens.
Short percentage is up to 65% on this low floater from yesterdays volume. Any sniff of FDA talks/approval/buyouts and we're going to have a major short squeeze here. Not very wise to short a low floater with insiders buying and potential news and updates coming. Insider buying (Form 4s) having been dropping recently.
https://www.otcshortreport.com/company/BIVI
BIVI Disclosures:
*Lots of SEC Form 4 (insider buying) filings recently by BIVI; some forms with exercisable dates dating back to 2017 and 2018 - any reason why they would be filing recently if the exercisable dates were well before the attorney signed off on them for SEC filing? Re-certification by attorney required after a certain time period? Possible uplisting to another exchange? Keeping current?
https://www.otcmarkets.com/stock/BIVI/disclosure
BioVie Twitter Page:
*No updates since 9 APR 2018 but they are active with SEC filings and press releases via OTCmarkets.com
https://twitter.com/biovie_inc?lang=en
NeurMedix -
*new IPO offering via Terren (as CEO again)
*Not sure where this guy gets the time to be CEO of a couple micro/small cap companies, and he's 58 years old.
Offering:
https://service.americasnextinvestment.com/offers/neurmedix
Twitter Account - NeurMedix:
*Created Nov 2018, recently
https://twitter.com/neurmedixipo?lang=en
Feb 6th Press Release:
“We are pleased to have achieved this important clinical milestone as we continue to develop BIV201 for patients with refractory ascites who are at high risk of deadly complications,” stated BioVie Chief Medical Officer Patrick Yeramian, MD. “What we have learned from this initial study is informing our next clinical trial design. The results will be presented to the FDA in the first half of 2019 and we expect to receive guidance on the BIV201 clinical development plan.”
https://irdirect.net/prviewer/release/id/3609971
BIVI MOVES LIKE LAST YEAR AGAIN!
...:)
593,535 BUYS vs. 126,219 sells as of 14:41:55
https://ih.advfn.com/stock-market/USOTC/biovie-inc-BIVI/trades
Followers
|
5
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
84
|
Created
|
10/18/08
|
Type
|
Free
|
Moderators |
BKF Capital Group, Inc.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |